September 3, 2024 Revolutionary Breakthrough: PCL’s Groundbreaking Early Dementia Diagnosis Technology Secures Russian Patent
September 2, 2024 Celltrion Pharmaceuticals begins domestic sales of 3 types including Ilia biosimilar